SAT-296 COST-EFFECTIVENESS ANALYSIS OF EMPAGLIFLOZIN TREATMENT IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE BASED ON SUBGROUP OF EMPA-REG OUTCOME
Keyword(s):
2009 ◽
Vol 11
(3)
◽
pp. 116-124
◽
2019 ◽
Vol 4
(2)
◽
pp. 277-286
◽
Keyword(s):